Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Naturally occurring catalytic antibodies: evidence for preferred development of the catalytic function in IgA class antibodies.

Mitsuda Y, Planque S, Hara M, Kyle R, Taguchi H, Nishiyama Y, Paul S.

Mol Biotechnol. 2007 Jun;36(2):113-22.

PMID:
17914190
2.

Characterization of gp120 hydrolysis by IgA antibodies from humans without HIV infection.

Planque S, Mitsuda Y, Taguchi H, Salas M, Morris MK, Nishiyama Y, Kyle R, Okhuysen P, Escobar M, Hunter R, Sheppard HW, Hanson C, Paul S.

AIDS Res Hum Retroviruses. 2007 Dec;23(12):1541-54.

PMID:
18160012
3.

Antigen-specific proteolysis by hybrid antibodies containing promiscuous proteolytic light chains paired with an antigen-binding heavy chain.

Sapparapu G, Planque SA, Nishiyama Y, Foung SK, Paul S.

J Biol Chem. 2009 Sep 4;284(36):24622-33. doi: 10.1074/jbc.M109.011858. Epub 2009 Jun 19.

4.

Nature and nurture of catalytic antibodies.

Paul S, Planque SA, Nishiyama Y, Hanson CV, Massey RJ.

Adv Exp Med Biol. 2012;750:56-75. doi: 10.1007/978-1-4614-3461-0_5.

PMID:
22903666
5.

Constant domain-regulated antibody catalysis.

Sapparapu G, Planque S, Mitsuda Y, McLean G, Nishiyama Y, Paul S.

J Biol Chem. 2012 Oct 19;287(43):36096-104. doi: 10.1074/jbc.M112.401075. Epub 2012 Sep 4.

6.

A Monoclonal Antibody to Cryptococcus neoformans Glucuronoxylomannan Manifests Hydrolytic Activity for Both Peptides and Polysaccharides.

Bowen A, Wear MP, Cordero RJ, Oscarson S, Casadevall A.

J Biol Chem. 2017 Jan 13;292(2):417-434. doi: 10.1074/jbc.M116.767582. Epub 2016 Nov 21.

PMID:
27872188
7.

Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain.

Sun M, Gao QS, Kirnarskiy L, Rees A, Paul S.

J Mol Biol. 1997 Aug 22;271(3):374-85.

PMID:
9268666
8.

Why specific anti-integrase antibodies from HIV-infected patients can efficiently hydrolyze 21-mer oligopeptide corresponding to antigenic determinant of human myelin basic protein.

Odintsova ES, Dmitrenok PS, Timofeeva AM, Buneva VN, Nevinsky GA.

J Mol Recognit. 2014 Jan;27(1):32-45. doi: 10.1002/jmr.2329.

PMID:
24375582
9.

Site-directed mutagenesis of proteolytic antibody light chain.

Gao QS, Sun M, Rees AR, Paul S.

J Mol Biol. 1995 Nov 10;253(5):658-64.

PMID:
7473741
10.

Natural catalytic antibodies.

Paul S.

Mol Biotechnol. 1996 Jun;5(3):197-207. Review.

PMID:
8837026
11.

Innate antibody catalysis.

Gololobov G, Sun M, Paul S.

Mol Immunol. 1999 Dec;36(18):1215-22.

PMID:
10684961
12.

Detection of anti-SS-A/Ro and anti-SS-B/La antibodies of IgA and IgG isotypes in saliva and sera of patients with Sjögren's syndrome.

Iwasaki K, Okawa-Takatsuji M, Aotsuka S, Ono T.

Nihon Rinsho Meneki Gakkai Kaishi. 2003 Dec;26(6):346-54.

PMID:
14752936
13.

Catalytic heterogenity of polyclonal RNA-hydrolyzing IgM from sera of patients with lupus erythematosus.

Andrievskaya OA, Buneva VN, Naumov VA, Nevinsky GA.

Med Sci Monit. 2000 May-Jun;6(3):460-70.

PMID:
11208354
14.

Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.

Brown EL, Nishiyama Y, Dunkle JW, Aggarwal S, Planque S, Watanabe K, Csencsits-Smith K, Bowden MG, Kaplan SL, Paul S.

J Biol Chem. 2012 Mar 23;287(13):9940-51. doi: 10.1074/jbc.M111.330043. Epub 2012 Feb 2.

15.
16.

Naturally occurring proteolytic antibodies: selective immunoglobulin M-catalyzed hydrolysis of HIV gp120.

Paul S, Karle S, Planque S, Taguchi H, Salas M, Nishiyama Y, Handy B, Hunter R, Edmundson A, Hanson C.

J Biol Chem. 2004 Sep 17;279(38):39611-9. Epub 2004 Jul 21.

17.

Investigations into the development of catalytic activity in anti-acetylcholinesterase idiotypic and anti-idiotypic antibodies.

Johnson G, Moore SW.

J Mol Recognit. 2009 May-Jun;22(3):188-96. doi: 10.1002/jmr.931.

PMID:
19051205
18.

Catalytic antibody activity elicited by active immunisation. Evidence for natural variation involving preferential stabilization of the transition state.

Gallacher G, Jackson CS, Searcey M, Goel R, Mellor GW, Smith CZ, Brocklehurst K.

Eur J Biochem. 1993 May 15;214(1):197-207.

19.

Analysis of paraprotein transport into the saliva by using anti-idiotype antibodies.

Kubagawa H, Bertoli LF, Barton JC, Koopman WJ, Mestecky J, Cooper MD.

J Immunol. 1987 Jan 15;138(2):435-9.

PMID:
3794339
20.

Anti-integrase abzymes from the sera of HIV-infected patients specifically hydrolyze integrase but nonspecifically cleave short oligopeptides.

Odintsova ES, Baranova SV, Dmitrenok PS, Calmels C, Parissi V, Andreola ML, Buneva VN, Nevinsky GA.

J Mol Recognit. 2012 Apr;25(4):193-207. doi: 10.1002/jmr.2159.

PMID:
22434709

Supplemental Content

Support Center